Edwards Lifesciences Corp. share price logo

Edwards Lifesciences Corp. Share Price

NYSE: EW

Large Cap

$77.61

-0.40

(-0.51%)

as on

Edwards Lifesciences Corp. Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $76.49
    $77.83
    downward going graph

    1.44%

    Downside

    0.28%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $64.01
    $83
    downward going graph

    17.53%

    Downside

    6.94%

    Upside

    downward going graph

Edwards Lifesciences Corp. share price movements today

Previous Close
$78.01
Open
$77.37
Volume
3.9M
Day's Low - High
$76.49 - $77.83
52 Week Low - High
$64.01 - $83

Edwards Lifesciences Corp. Historical Returns

1 Month Return
-0.14 %
3 Month Return
+ 3.22 %
1 Year Return
+ 13.21 %
3 Year Return
-17.72 %
5 Year Return
-5.15 %

Edwards Lifesciences Corp. Stock Fundamentals & Key Indicators

Check Edwards Lifesciences Corp. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$45.5B

EPS (TTM)

2.5022

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.07%

PE Ratio (TTM)

32.46

Industry PE ratio

16.65525641025641

P/B Ratio

32.4561

PEG Ratio

4.2026

EBITDA

1.7B

Revenue (TTM)

5.7B

Profit Margin

72.96%

Return On Equity TTM

15.53%

Edwards Lifesciences Corp. Stock Valuation

Track how Edwards Lifesciences Corp. P/E has moved over time to understand its valuation trends.

Edwards Lifesciences Corp. in the last 5 years

  • Overview

  • Trends

Lowest (26.71x)

December 31, 2024

Industry (16.66x)

September 13, 2025

Today (32.46x)

September 13, 2025

Highest (52.31x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 32.46x

Edwards Lifesciences Corp. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Edwards Lifesciences Corp. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$45.5B-5.15%32.4672.96%
BUY$152.2B154.93%61.1413.55%
BUY$146.6B89.75%50.7712.25%
BUY$232.8B27.73%16.7832.43%
BUY$120.6B-10.25%25.9813.63%

Stock Returns calculator for Edwards Lifesciences Corp. Stock including INR - Dollar returns

The Edwards Lifesciences Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Edwards Lifesciences Corp. investment value today

Current value as on today

₹1,18,405

Returns

₹18,405

(+18.41%)

Returns from Edwards Lifesciences Corp. Stock

₹13,266 (+13.27%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Edwards Lifesciences Corp. Stock

Based on 40 analysts

BUY

60.00%

Buy

35.00%

Hold

5.00%

Sell

Based on 40 analysts, 60% of analysts recommend a 'BUY' rating for Edwards Lifesciences Corp.. Average target price of $87.73

Edwards Lifesciences Corp. Share Price Target

Get share price movements and forecasts by analysts on Edwards Lifesciences Corp..

What analysts predicted

11.54%UPSIDE

Target Price

$87.73

Current Price

$77.61

Analyzed by

40 Analysts

Target

$87.73

Edwards Lifesciences Corp. target price $87.73, a slight upside of 11.54% compared to current price of $77.61. According to 40 analysts rating.

Edwards Lifesciences Corp. Stock's Interest Amongst Investors

Search interest for Edwards Lifesciences Corp. Stock has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-35% versus previous 30 day period

Edwards Lifesciences Corp. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
1,459
1,295
1,243
1,266
1,329
1,385
1,354
1,385
1,412
1,532
Gross Profit
1,100
1,024
971
1,015
1,040
1,088
1,091
1,093
1,111
1,189
Operating Income
402
370
346
356
355
364
350
312
394
430
EBITDA
440
311
424
403
409
426
428
483
470
400
Interest Expense
10
9
-
27
-
-
-
-
-
-
Depreciation
35
36
36
36
38
39
34
42
36
38
Income Before Tax
398
275
387
367
371
386
402
390
433
400
Income Tax Expense
58
20
52
34
46
20
40
45
70
64
Net Income
340
307
384
369
351
363
3,070
385
358
329
Net Profit Margin
23.33%
23.71%
30.96%
29.21%
26.46%
26.24%
226.73%
27.83%
25.34%
21.52%

Edwards Lifesciences Corp. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
2,493
2,963
3,435
3,722
4,348
4,386
5,232
5,382
6,004
5,439
Gross Profit
1,809
2,157
2,552
2,800
3,192
3,287
4,006
4,215
4,625
4,322
Operating Income
575
815
1,010
1,092
1,197
1,296
1,610
1,702
1,534
1,378
EBITDA
706
827
1,140
872
1,308
1,074
1,890
1,960
1,534
1,723
Interest Expense
18
18
23
33
27
22
24
26
17
19
Depreciation
-
-
81
77
89
107
134
139
143
155
Income Before Tax
622
737
1,034
761
1,166
916
1,702
1,767
1,598
1,548
Income Tax Expense
127
168
451
39
119
93
198
245
198
152
Net Income
494
569
622
722
1,046
823
1,503
1,521
1,402
4,174
Net Profit Margin
19.85%
19.22%
18.11%
19.40%
24.08%
18.77%
28.73%
28.28%
23.35%
76.75%

Edwards Lifesciences Corp. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
305
383
369
351
365
3,069
356
358
331
Operating Cash Flow
33
411
136
-53
371
351
280
280
290
Investing Cash Flow
70
89
14
63
124
2,701
85
85
-172
Financing Cash Flow
52
-143
-413
61
-96
-976
-258
-258
52
Change in Cash
171
366
-265
81
429
2,035
90
90
141

Edwards Lifesciences Corp. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
569
583
722
1,046
823
1,503
1,521
1,402
4,169
Operating Cash Flow
704
1,000
926
1,179
1,054
1,732
1,218
895
542
Investing Cash Flow
-211
-647
76
-595
-531
-1,722
252
173
2,312
Financing Cash Flow
-268
-473
-1,101
-115
-486
-356
-1,584
-711
-983
Change in Cash
211
-111
-104
465
15
-332
-94
375
1,910

Global Institutional Holdings in Edwards Lifesciences Corp.

Funds
Holdings
Vanguard Group Inc
11.79%
BlackRock Inc
9.32%
Wellington Management Company LLP
4.96%
State Street Corp
4.39%
JPMorgan Chase & Co
3.74%

Insights on Edwards Lifesciences Corp.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Edwards Lifesciences Corp. has shown consistent revenue growth over the past four quarters, increasing from $1.35 billion to $1.53 billion. This represents an average quarterly increase of 4.0%.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Boston Scientific Corp. has given 23.3% return, outperforming this stock by 10.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Boston Scientific Corp. has given 143.4% return, outperforming this stock by 161.6%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Edwards Lifesciences Corp. has experienced a decline in net profit over the last four quarters. The profit dropped significantly from $3.07 billion to $329.8 million, averaging a decrease of 34.2% each quarter.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, EW stock has moved down by -3.2%

About Edwards Lifesciences Corp.

edwards lifesciences (nyse: ew) is the global leader in the science of heart valves and hemodynamic monitoring. driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. headquartered in irvine, california, edwards lifesciences has extensive operations in north america, europe, japan, latin america and asia and currently employs about 6,400 individuals worldwide. for us, helping patients is not a slogan – it's our life’s work. from developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.
OrganisationEdwards Lifesciences Corp.
HeadquartersOne Edwards Way, Irvine, CA, United States, 92614
IndustryHealth Technology
CEOMr. Bernard J. Zovighian
E-voting on sharesClick here to vote

Key Management of Edwards Lifesciences Corp.

Name

Title

Mr. Scott B. Ullem

Corporate VP & CFO

Mr. Jean-Luc Lemercier

Corporate Vice President of Japan, Asia Pacific & Greater China

Mr. Andrew M. Dahl

Principal Accounting Officer, Senior VP & Corporate Controller

Mr. Dirksen J. Lehman

Corporate Vice President of Public Affairs

Mr. Mark Wilterding

Vice President of Investor Relations

Mr. Mark D. Peterson

Corporate VP & General Counsel

Mr. Bernard J. Zovighian

CEO & Director

Mr. Donald E. Bobo Jr.

Corporate Vice President of Strategy & Corporate Development

Mr. Daveen Chopra

Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies

Dr. Todd J. Brinton FACC, M.D.

Corporate VP of Advanced Technology & Chief Scientific Officer

FAQs

What is Edwards Lifesciences Corp. share price today?

Edwards Lifesciences Corp. share price today is $77.61 as on at the close of the market. Edwards Lifesciences Corp. share today touched a day high of $77.83 and a low of $76.49.

What is the 52 week high and 52 week low for Edwards Lifesciences Corp. share?

Edwards Lifesciences Corp. share touched a 52 week high of $83 on and a 52 week low of $64.01 on . Edwards Lifesciences Corp. stock price today i.e. is closed at $77.61,which is 6.49% down from its 52 week high and 21.26% up from its 52 week low.

What is Edwards Lifesciences Corp.'s market capitalisation today?

Edwards Lifesciences Corp. market capitalisation is $0.05T as on .

How to invest in Edwards Lifesciences Corp. Stock (EW) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Edwards Lifesciences Corp. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Edwards Lifesciences Corp. Shares that will get you 0.0193 shares as per Edwards Lifesciences Corp. share price of $77.61 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Edwards Lifesciences Corp. Stock (EW) from India?

Indian investors can start investing in Edwards Lifesciences Corp. (EW) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Edwards Lifesciences Corp. stock (as per the Rupee-Dollar exchange rate as on ). Based on Edwards Lifesciences Corp. share’s latest price of $77.61 as on September 13, 2025 at 1:29 am IST, you will get 0.1288 shares of Edwards Lifesciences Corp.. Learn more about fractional shares .

What are the returns that Edwards Lifesciences Corp. has given to Indian investors in the last 5 years?

Edwards Lifesciences Corp. stock has given -5.15% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?